0864-0289 0864-0289 S0864-02892021000100012 Cuba Colombia 00 03 2021 00 03 2021 37 1

1 2003 101 2 2 407-14 2 2013 122 12 12 2135-41 3 1965 2 5463 5463 663-4 4 2019 29 3 3 5 2017 129 16 16 2316-25 6 2005 36 9 9 757-69 7 2015 90 2 2 626-9 8 2014 20 12 12 1958-67 9 2018 31 2 2 76-9 10 2016 22 7 7 1275-83 11 2000 95 7 7 2240-5 12 2018 53 11 11 1450-6 13 2012 119 2 2 399-410 14 2005 202 5 5 673-85 15 2011 121 5 5 1673-80 16 2011 46 8 8 1089-98 17 2013 57 1-3 1-3 140-50 18 2011 46 8 8 1089-98 19 2017 10 4 4 233-8 20 2009 22 1 1 76-98 21 2000 74 17 17 8140-50 22 2016 8 1 1 23 2011 11 4 4 284-92 24 2013 369 13 13 1227-36 25 2014 370 19 19 1781-9 26 2015 162 1 1 1-10 27 2019 21 4 4 28 2018 7 1 1 1-16 29 2017 377 25 25 2433-44 30 2017 64 1 1 87-91 31 2017 European Conference on Infections in Leukaemia group 2019 19 8 8 e260-72 32 2002 34 8 8 1094-7 33 2019 68 8 8 1420-14 34 1991 324 15 15 1005-11 35 1994 47 11 11 968-72 36 2016 4 4 4 37 2018 102 6 6 900-31 38 Eleventh 39 Grupo de Patología Infecciosa AEPap 2014 40 2013 56 3 3 374-5 41 Collaborative Study Group 2016 44 4 4 242-51 42 2011 52 3 3 222-4 43 2012 54 12 12 1793-7 44 2015 53 4 4 1252-7 45 2017 4 3 3 46 2000 38 6 6 2122-7 47 2003 37 12 12 1603-6 48 1994 794-6 49 2019 19 9 9 2479-94 50 2013 369 13 13 1227-36 51 2014 370 19 19 1781-9 52 2018 102 2 2 326-32 53 1991 324 15 15 1057-9 54 1991 325 23 23 1601-7 55 2016 3 3 3 e119-27 56 2017 69 179-83 57 2014 52 2 2 654-6 58 2000 26 4 4 413-7 59 2016 18 3 3 390-5 60 2016 100 10 10 e74-80 61 2011 11 4 4 284-92 62 European Medicines Agency (EMA) 2017 63 AEMPS 64 2017 377 25 25 2433-44 65 2019 21 6 6 66 2019 63 3 3 e02337-18 67 2019 68 8 8 1255-64 68 2017 138 57-60 69 2018 157 128-33 70 2018 100 61-6 71 2017 215 11 11 1684-94 72 2016 127 20 20 2427-38 73 2016 7 507 74 2017 23 7 7 1046-53 75 2012 205 8 8 1294-304 76 2016 3 2 2 e87-98